Outcome and safety of colistin usage in pediatric cancer patients with carbapenem-resistant enterobacteriaceae bacteremia at children cancer hospital Egypt.

Adel N, Khedr R, Elanany M, Zaki HF, Hafez H, El-Abhar H

Open source

DOI
10.4103/aam.aam_209_21
Published
2023 Jan-Mar
Container
Annals of African medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4103/aam.aam_209_21,
  title = {Outcome and safety of colistin usage in pediatric cancer patients with carbapenem-resistant enterobacteriaceae bacteremia at children cancer hospital Egypt.},
  author = {Adel N and Khedr R and Elanany M and Zaki HF and Hafez H and El-Abhar H},
  year = {2023},
  journal = {Annals of African medicine},
  doi = {10.4103/aam.aam_209_21},
  url = {https://doi.org/10.4103/aam.aam_209_21}
}

RIS

TY  - JOUR
TI  - Outcome and safety of colistin usage in pediatric cancer patients with carbapenem-resistant enterobacteriaceae bacteremia at children cancer hospital Egypt.
AU  - Adel N
AU  - Khedr R
AU  - Elanany M
AU  - Zaki HF
AU  - Hafez H
AU  - El-Abhar H
PY  - 2023
JO  - Annals of African medicine
DO  - 10.4103/aam.aam_209_21
UR  - https://doi.org/10.4103/aam.aam_209_21
ER  - 

APA

N, A., R, K., M, E., HF, Z., H, H., & H, E. (2023). Outcome and safety of colistin usage in pediatric cancer patients with carbapenem-resistant enterobacteriaceae bacteremia at children cancer hospital Egypt.. Annals of African medicine. https://doi.org/10.4103/aam.aam_209_21

Source records